Canuevo Biotech

Canuevo Biotech Inc. specializes in the development of cannabinoid (CBD) formulations and innovative drug delivery mechanisms aimed at improving efficacy for various medical conditions. Founded in 2017 and based in Fredericton, Canada, the company designs custom vessels for encapsulated CBD, producing a range of products including skin creams and tablets. Canuevo's offerings target neurological disorders such as epilepsy and seizures, movement disorders like Parkinson’s and Alzheimer’s, chronic inflammation, and other conditions including irritable bowel syndrome and support for opiate dependency. The company addresses the challenges of standardization and acceptance of cannabis-derived medications within the medical and regulatory spheres, selling its products online to reach a broader audience.